Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium falciparum redox metabolism encompasses all of the parasite's metabolic systems that maintain intracellular redox homeostasis, protecting it from oxidative stress generated during its complex lifecycle inside erythrocytes. This includes the glutathione and thioredoxin systems, multiple antioxidant enzymes, and associated metabolites and transport proteins. The redox balance is vital for parasite survival, supporting essential processes such as nutrient acquisition, protein export, and defense against host-derived or drug-induced reactive oxygen species. Several antimalarial drugs—including frontline treatments like artemisinin and newer synthetic ozonides—exert their actions by disrupting these redox pathways, primarily through selective alkylation and inactivation of redox enzymes and creating oxidative damage that the parasite cannot repair. As a therapeutic concept, "Plasmodium falciparum redox metabolism" is a validated target for antimalarial intervention, although it comprises numerous molecular entities rather than a single protein or receptor[1][2][3][6]. Because the term describes a network rather than a discrete target, further work is required to specify individual target proteins within the system for drug development or biomarker selection. Additional notes: - This entry is not a specific molecular target but a collective term for a functionally related pathway network; therefore, "Plasmodium falciparum redox metabolism" as a target is accurate at the pathway level but imprecise for the context of single-molecule targeting[1][2][3]. - Key molecular components include glutathione reductase, thioredoxin reductase, peroxiredoxins, and glyoxalase system proteins[2][3]. - Experimental disruption (gene knockout or chemical inhibition) and drug-induced oxidative stress in this pathway lead to parasite death, supporting its centrality in malaria pathogenesis and therapy[1][3][6].
Protein alkylation by peroxides (artemisinins and ozonides); Disruption of glutathione and thioredoxin systems; Induction of lethal oxidative stress by targeting redox homeostasis; Inhibition of antioxidant enzymes or pathways
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum redox metabolism.